Key facts
- This page summarizes David S. Thomson's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Jun 2021, 07:59.
David S. Thomson - 23 Jun 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- DTIL
- Reported as of
- 23 Jun 2021
- Net transaction value
- -$284,100
- SEC form
- 4
- Accepted by SEC
- 25 Jun 2021, 07:59:32 UTC
- Prior SEC filing
- 23 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dario Scimeca, Attorney-in-Fact for David S. Thomson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David S. Thomson filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 25 Jun 2021.
Change
- Previous filing in this sequence was filed on 23 Jun 2021.
- Current net transaction value: -$284,100.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
transaction
Common Stock
Options Exercise
- Transaction value
- $35,400
- Shares
- +30,000
- Change %
- +27%
- Price
- $1.18
- Shares after
- 141,513
- Date
- 23 Jun 2021
- Ownership
- Direct
DTIL
transaction
Common Stock
Sale
- Transaction value
- $319,500
- Shares
- -30,000
- Change %
- -21%
- Price
- $10.65
- Shares after
- 111,513
- Date
- 23 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -61%
- Price
- $0.000000
- Shares after
- 19,255
- Date
- 23 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $1.18
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.61 to $10.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
The option is fully vested and exercisable.